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Abstract 
Background: (2S)‑Pinocembrin is a chiral flavanone with versatile pharmacological and biological activities. Its 
health‑promoting effects have spurred on research effects on the microbial production of (2S)‑pinocembrin. However, 
an often‑overlooked salient feature in the analysis of microbial (2S)‑pinocembrin is its chirality.
Results: Here, we presented a full characterization of absolute configuration of microbial (2S)‑pinocembrin from 
engineered Escherichia coli. Specifically, a transcriptome‑wide search for genes related to (2S)‑pinocembrin biosynthe‑
sis from Ornithogalum caudatum, a plant rich in flavonoids, was first performed in the present study. A total of 104,180 
unigenes were finally generated with an average length of 520 bp. The Kyoto Encyclopedia of Genes and Genomes 
(KEGG) pathway mapping assigned 26 unigenes, representing three enzyme families of 4‑coumarate:coenzyme A 
ligase (4CL), chalcone synthase (CHS) and chalcone isomerase(CHI), onto (2S)‑pinocembrin biosynthetic pathway. A 
total of seven, three and one full‑length candidates encoding 4CL, CHS and CHI were then verified by reverse tran‑
scription polymerase chain reaction, respectively. These candidates were screened by functional expression in E. coli 
individual or coupled multienzyme reaction systems based on metabolic engineering processes. Oc4CL1, OcCHS2 
and OcCHI were identified to be bona fide genes encoding respective pathway enzymes of (2S)‑pinocembrin bio‑
synthesis. Then Oc4CL1, OcCHS2 and MsCHI from Medicago sativa, assembled as artificial gene clusters in different 
organizations, were used for fermentation production of (2S)‑pinocembrin in E. coli. The absolute configuration of 
the resulting microbial pinocembrin at C‑2 was assigned to be 2S‑configured by combination of retention time, UV 
spectrum, LC–MS, NMR, optical rotation and circular dichroism spectroscopy. Improvement of (2S)‑pinocembrin titres 
was then achieved by optimization of gene organizations, using of codon‑optimized pathway enzymes and addition 
of cerulenin for increasing intracellular malonyl CoA pools. Overall, the optimized strain can produce (2S)‑pinocembrin 
of 36.92 ± 4.1 mg/L.
Conclusions: High titre of (2S)‑pinocembrin can be obtained from engineered E. coli by an efficient method. The 
fermentative production of microbial (2S)‑pinocembrin in E. coli paved the way for yield improvement and further 
pharmacological testing.
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Background
Pinocembrin (1, Fig.  1), also named 5, 7-dihydroxyfla-
vanone or dihydrochrysin, is a kind of chiral flavonoid 
made up of two enantiomer forms, (2S)-pinocembrin 
(2, Fig. 1) and (2R)-pinocembrin (3, Fig. 1). Unlike infre-
quent (2R)-pinocembrin (3) [1, 2], (2S)-pinocembrin 
(2) was shown to widely occur in most of the propolises 
[3–5] and plants, like Cryptocarya chingii [6], Quincha-
malium majus Brong [7] and Glycyrrhiza glabra [8]. 
(2S)-pinocembrin (2) exerts versatile pharmacological 
and biological activities including antimicrobial proper-
ties [5, 9, 10], anticancer activity [10, 11], anti-inflamma-
tory effect [9, 10] and antioxidant action [9, 10], which 
makes it a promising compound with pharmaceutical 
potential. The racemic pinocembrin (1) had been there-
fore approved to enter phase II clinical trials as a poten-
tial therapeutic for stroke by the State Food and Drug 
Administration of China [12].
(2S)-pinocembrin (2) is obtained by extracting from 
plants [6–8] or propolis [4, 11], chemical synthesis [13–
16] and microbial production by metabolic engineering 
or synthetic biology [17–20]. Although plants or propo-
lis are still a primary source of (2S)-pinocembrin (2) 
[21–24], the production of plant- or propolis-derived 
(2S)-pinocembrin (2) is hampered by the low availabil-
ity and complicated purification procedures. Apart from 
natural sources, it has been noted that (2S)-pinocembrin 
(2) can be chemically synthesized. However, chemical 
synthesis faces several obstacles such as the usage of toxic 
chemicals, extreme reaction conditions and sophisticated 
enantiomeric resolution [13, 14, 16, 25]. In response to 
the poor yield of extraction from natural sources and 
poor chemical synthesis efficiency, research groups have 
directed their attention to the microbial production of 
(2S)-pinocembrin (2) [18–20]. This approach expresses 
the biosynthetic pathway of (2S)-pinocembrin (2) in 
many more amenable heterologous hosts to improve 
pinocembrin yields with a more economical and environ-
ment-friendly manner.
The biosynthesis of (2S)-pinocembrin (2) begins with 
the phenylpropanoid pathway, in which trans-cinnamic 
acid (5, t-CA) is used to generate trans-cinnamoyl CoA 
(10) by 4-coumarate:coenzyme A ligase(4CL). Chalcone 
synthase (CHS) catalyzes the stepwise condensation of 
three acetate units from malonyl CoA (17) with trans-
cinnamoyl CoA (10) to yield pinocembrin chalcone (4). 
The latter is then converted to (2S)-pinocembrin (2) 
by the action of chalcone isomerase (CHI) in vivo or to 
racemic pinocembrin non-enzymatically (Fig.  2). The 
health-promoting effects of (2S)-pinocembrin (2) have 
spurred on research efforts towards the development of 
microbial production platforms using phenylpropanoid 
and flavonoid biosynthetic enzymes [18, 26–30]. Up to 
date, pinocembrin has been obtained from engineered 
Escherichia coli [18, 20, 31], Saccharomyces cerevisiae 
[29, 30] and Streptomyces venezuelae [27] by combi-
national expression of pathway enzymes with diverse 
genetic sources. These studies, although valuable, have 
a distinct defect, namely no full characterization of ste-
reochemistry of microbial (2S)-pinocembrin (2). Besides 
this, it will be necessary to test much more structural 
genes coming from varied origins because the cloning 
and the characterization of diverse genes can offer new 
perspectives in the development of recombinant micro-
organisms capable of a high and optimized production 
of microbial (2S)-pinocembrin (2). With these in mind, 
this study describes the isolation and functional expres-
sion of enzymes related to a complete (2S)-pinocembrin 
(2) pathway from Ornithogalum caudatum for the first 
time. Importantly, these enzymes were then used to suc-
cessfully rebuild a biosynthetic circuit in E. coli to acquire 
(2S)-pinocembrin (2), which broadened the genetic 
sources of gene parts used for microbial (2S)-pinocem-
brin (2) production. What’s more, the present study fully 
characterized the absolute configuration of microbial 
(2S)-pinocembrin (2), which is uniquely value for yield 
improvement and further pharmacological testing of chi-
ral (2S)-pinocembrin (2).
Results
KEGG pathway analysis of O. caudatum unigenes
The transcriptome is the universe of expressed tran-
scripts within a cell at some particular state. Transcrip-
tome sequencing is a high-throughput approach and can 
yield a tremendous amount of sequences in each run, far 
greater than that produced by traditional techniques. 
Transcriptome sequencing, therefore, can greatly accel-
erate full-length genes isolation. In the present study, 
a total of 104,180 unigenes with an average length of 
520 bp were acquired from transcriptome de novo assem-
bly. These unigene sequences were aligned to KEGG 
pathways by KEGG analysis. Results showed varied uni-
genes were assigned to every step of (2S)-pinocembrin 
(2) biosynthesis (Additional file 1: Table S1). Totally, 19, 
3 and 4 unigenes showing high similarity with 4CL, CHS 
and CHI were retrieved from transcriptome sequence, 
Keywords: (2S)‑Pinocembrin, Ornithogalum caudatum, Metabolic engineering, 4‑Coumarate:coenzyme A ligase, 
Chalcone synthase, Chalcone isomerase
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respectively (Additional file  1: Table S1). These uni-
genes were further analyzed by BLAST X for their ORF 
(open reading frame) identification. Some of these uni-
genes were predicted to contain full-length complemen-
tary DNA (cDNA) sequences and the others had partial 
cDNA encoding sequences.
These predicted full-length cDNA sequences can be 
isolated from O. caudatum cDNA directly by nested pol-
ymerase chain reaction (PCR). The missing sequences of 
these tentatively partial cDNA, however, were obtained 
mainly by RACE (rapid amplification of cDNA end) [32]. 















R1=OH, R2=R3=H, p-coumaric acid(6)
R1=R2=OH, R3=H, caffeic acid(7)
R1=OH, R2=OCH3, R3=H, ferulic acid(8)
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Fig. 1 Chemical structures of compounds investigated in this study
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4CL-like sequences, three CHS-like cDNA and one full-
length CHI-like fragment, were isolated from O. cauda-
tum (Additional file 1: Table S1). All of these ORFs were 
then inserted to the cloning vector pEASY™-T1 Simple 
vector for sequencing. The results verified that these 
cDNA sequences were identical with the result from 
transcriptome sequencing, which means the real genes in 
planta. Therefore, these sequences were deposited in the 
GenBank database (Table 1).
cDNA isolation and functional characterization of 4CL gene 
family
A 4CL gene family harboring seven full-length cDNAs, 
namely Oc4CL1-7, was isolated from O. caudatum by 
nested PCR (Table  1). These cDNAs were cloned into 
pEASY™-T1 to generate pEASY-Oc4CLs for sequenc-
ing. After sequences verification, the Oc4CL genes were 
cloned into E. coli vector pET-28a (+) resulting in recom-
binant vectors pET28a-Oc4CLs for heterologous expres-
sion by In-Fusion® method, respectively.
Various pET28a-Oc4CLs were transformed into E. coli 
Transetta (DE3) to acquire engineered E. coli [pET28a-
Oc4CLs] for heterologous expression of Oc4CLs. Both 
SDS–PAGE (sodium dodecyl sulfate polyacrylamide gel 
electrophoresis, Additional file  2: Fig. S1) and Western-
blot (Additional file 3: Fig. S2) results demonstrated that 
there were indeed Oc4CL proteins expressed in the E. 
coli culture.
Following induction of transformed E. coli cells with 
isopropyl-β-d-thiogalactopyranoside (IPTG), the crude 
extracts of E. coli [pET28a-Oc4CLs] were used to per-
form enzyme assays using six possible substrates, viz., 
trans-cinnamic (5), p-coumaric (6), caffeic (7), feru-
lic (8), sinapic (9) and benzoic (15) acids, respectively. 
High-performance liquid chromatography-diode array 

















































Fig. 2 Biosynthetic pathway of (2S)‑pinocembrin (2)
Table 1 Full-length cDNAs related to  (2S)-pinocembrin (2) 
biosynthesis
Gene nt (bp) Polypeptide (aa) Accession number
Oc4CL1 1638 545 KF241990.1
Oc4CL2 1644 547 KM393177.1
Oc4CL3 1566 521 KM393178.1
Oc4CL4 1710 569 KM393179.1
Oc4CL5 1644 547 KM393180.1
Oc4CL6 1695 564 KM393181.1
Oc4CL7 1623 540 KM393182.1
OcCHS1 1149 382 KM393183.1
OcCHS2 1173 390 KM393184.1
OcCHS3 1152 383 KM393185.1
OcCHI 633 210 KR822738.1
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reactions with substrates 5–8 (Fig. 3). The UV-Vis spec-
tras of these products were identical with standard com-
pounds reported early [33–36]. No products, however, 
were found in the reaction system with compounds 9 or 
15 as a substrate (Data not shown). LC–MS analyses of 
compounds 5–8, namely substrates R2, X2, C2 and A2 
and their corresponding products R1, X1, C1 and A1 dis-
played their [M-H]− ions at m/z 148.1, 164.1, 180.0, 194.1, 
896.2, 912.2, 928.2 and 942.2, corresponding to the calcu-
lated mass for trans-cinnamic acid (5), p-coumaric acid 
(6), caffeic acid (7), ferulic acid (8) and their correspond-
ing CoA thioesters. To study further the structure of 
products R1, X1, C1 and A1, 8 mg purified products each 
were produced by HPLC and applied to NMR (Table 2). 
The 1H NMR spectrum of R1 showed the signals of fol-
lowing protons: one set of A2B2X type aromatic protons 
at δ 7.37 (3H, m, H-27, H-28, H-30), 7.43 (2H, dd, J = 1.5, 
8.0  Hz, H-3′, H-5′), and 7.49 (2H, d, J  =  7.8  Hz, H-2′, 
H-6′), as well as a pair of trans-coupled olefinic proton 
signals at δ 6.66 (1H, d, J = 16.0 Hz, H-23) and 7.33 (1H, 
d, J  =  16.0  Hz, H-24) ascribable to the styrene moiety; 
two independent aromatic protons at δ 8.01 (1H, s, H-2), 
and 8.31 (1H, s, H-5), as well as proton signals for a ribo-
furanose at δ 5.99 (1H, d, J = 6.0 Hz, H-6), 4.70 (1H, br 
m, H-7), 4.67 (1H, br m, H-8), 4.48 (1H, br m, H-9), and 
4.18 (2H, br m, H-10) attributable to the adenosine unit. 
In addition, R1 showed a series of methylene protons at 
δ 3.49 (1H, m, H-11a), 3.77 (1H, m, H-11b), 3.39 (2H, m, 
H-17), 2.39 (2H, m, H-18), 3.34 (2H, m, H-20) and 3.05 
(2H, m, H-21), as well as a methine proton at δ 3.95 (1H, 
m, H-15) assignable to the side chain of coenzyme A. The 
13C NMR spectrum presented signals of two carbonyl 
at δ 177.6 (C-16), 176.9 (C-19), as well as five aromatic 
carbons at δ 158.3 (C-1), 155.6 (C-2), 152.0 (C-3), 121.4 
(C-4), and 142.4 (C-5), which were in agreement with the 
coenzyme A unit. The 13C NMR spectrum also displayed 
carbon signals assignable to a cinnamoyl group at δ 196.1 
(C-22), 127.0 (C-23), 144.5 (C-24), 133.9 (C-25), 131.3 
(C-26, C-30), 131.9 (C-27, C-29) and 136.3 (C-30). Based 
on the above observations, compound R1 was assigned as 
trans-cinnamoyl-CoA (10). Careful analyses of NMR (1H, 
13C) spectra revealed the structure of X1 was similar to 
that of R1, except that the cinnamoyl group was replaced 
by a p-coumaroyl group in X1. The 1H NMR spectrum of 
X1 displayed one set of A2B2 type aromatic protons at δ 
7.22 (2H, dd, J = 1.5, 9.0 Hz, H-26, H-30), 6.70 (2H, dd, 
J = 1.5, 9.0 Hz, H-27, H-29) attributable to the p-hydroxy-
benzoyl unit. The 13C NMR spectrum of X1 also exhib-
ited carbon signals at δ 128.5 (C-25), 118.7 (C-26, C-30), 
133.5 (C-27, C-29), and 161.3 (C-28) assignable to a 
p-hydroxybenzoyl moiety. Thus compound X1 was eluci-
dated as 4-coumaroyl CoA (11). By analysis of the NMR 
(1H, 13C) spectroscopic data, compound C1 was found to 
be identical with R1 except for the difference of benzene 
ring of the styrene moiety. The 1H NMR spectrum of C1 
exhibited one set of ABX aromatic protons which were 
Fig. 3 HPLC analysis of reaction products from E. coli [pET28a] (1), heat denatured protein extracts derived from E. coli [pET28a‑Oc4CL1] (2) and 
crude protein extracts of E. coli [pET28a‑Oc4CL1] (3) using trans‑cinnamic acid (a), ρ‑coumaric acid (b), caffeic acid (c), and ferulic acid (d) as the 
substrates. R2, X2, C2, A2, R1, X1, C1 and A1 refer to substrates trans‑cinnamic acid (5), ρ‑coumaric acid (6), caffeic acid (7), ferulic acid (8), and their 
corresponding products trans‑cinnamoyl CoA (10), 4‑coumaroyl CoA (11), caffeoyl CoA (12) and feruloyl CoA (13), respectively. Detection was set 
at 270 nm for reaction product of trans‑cinnamic acid (5), 320 nm for enzymatic products of ρ‑coumaric acid (6), caffeic acid (7) and ferulic acid (8). 
mAU Milliabsorbance units
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ascribable to a 3, 4 – dihydroxyphenyl moiety at δ 6.83 
(1H, br s, H-26), 6.74 (1H, d, J = 8.5 Hz, H-29), and 6.79 
(1H, dd, J = 1.5, 8.5 Hz, H-30). The 13C NMR spectrum of 
C1 displayed carbon signals for caffeoyl group at δ195.7 
(C-22), 124.3 (C-23), 144.7 (C-24), 128.9 (C-25), 113.7 
(C-26), 150.9 (C-27), 150.2 (C-28), 118.3 (C-29), and 126.5 
(C-30). On the basis of these observation, compound C1 
was assigned as caffeoyl-CoA (12). A comparsion of the 
NMR (1H, 13C) spectral data of C1 with those of A1 indi-
cated the latter differed from C1 only in the moiety at 
C-27 of the caffeoyl moiety. Instead of a caffeoyl unit of 
C1, a methoxyl was connected to the C-27 and a feruloyl 
group was present in A1. According to the results of 1H 
NMR and 13C NMR spectral data, compound A1 was elu-
cidated as feruloyl-CoA (13).
The other six Oc4CL proteins, however, showed no reac-
tive action with any substrates. The enzymatic properties 
were determined by the purified Oc4CL1 with His6-tag 
in N-terminal. The final content of the purified proteins 
were 0.0808  mg/mL. The optimum pH of the Oc4CL1 
was 7.98. It was stable at pH 6–10, and retained more than 
85 % activity even at pH 11. The optimal temperature for 
Oc4CL activity was 30 °C. The enzyme retained 80.80 and 
77.44  % even at 40 and 50  °C, respectively. The kinetic 
parameters of recombinant Oc4CL1 were determined in 
an enzyme activity assay using compounds 5–8 as the sub-
strates, respectively. Kinetic parameters of Oc4CL1 against 
various phenylpropanoid substrates were listed in Table 3. 
As showed in Table  3, the best substrate for Oc4CL is 
p-coumaric acid (6), with 16.42 μM of Km value.
Table 2 1H and 13C NMR data for compounds R1, X1, C1 and A1 (500 MHz for 1H NMR and 125 MHz for 13C NMR, D2O, J 
in Hz, δ in ppm)
Position R1 X1 A1 C1
δH δC δH δC δH δC δH δC
1 158.3 158.1 158.0 158.1
2 8.01 (1H, s) 155.6 7.97 (1H, s) 155.3 7.97 (1H, s) 155.3 8.00 (1H, s) 155.3
3 152.0 151.8 151.7 151.7
4 121.4 121.3 121.3 121.3
5 8.31 (1H, s) 142.5 8.32 (1H, s) 142.4 8.04 (1H, s) 142.3 8.31 (1H, s) 142.3
6 5.99 (1H, d, J 6.0) 89.4 5.95 (1H, d, J 6.0) 89.5 6.01 (1H, d, J 8.5) 89.6 5.95 (1H, d, J 6.0) 89.5
7 4.70 (1H, br m) 77.1 4.73 (1H, br m) 77.1 4.80 (1H, br m) 77.1 4.70 (1H, br m) 77.1
8 4.67 (1H, br m) 76.5 4.67 (1H, br m) 76.4 4.73 (1H, br m) 76.3 4.70 (1H, br m) 76.3
9 4.48 (1H, br m) 86.6 4.47 (1H, br m) 86.3 4.55 (1H, br m) 86.4 4.47 (1H, br m) 86.4
10 4.18 (2H, br m) 68.5 4.20 (2H, br m) 68.3 4.28 (2H, br m) 68.4 4.20 (2H, br m) 68.4
11 3.49 (1H, m); 3.77 (1H, m) 74.9 3.50 (1H, m); 3.77 (1H, m) 74.8 3.59 (1H, m); 3.83 (1H, m) 74.7 3.77 (2H, m) 74.8
12 41.2 41.2 41.2 41.2
13 0.83 (3H, s) 23.7 0.82 (3H, s) 23.7 0.91 (3H, s) 23.7 0.82 (3H, s) 23.7
14 0.70 (3H, s) 21.2 0.69 (3H, s) 21.2 0.78 (3H, s) 21.3 0.69 (3H, s) 21.2
15 3.95 (1H, m) 77.1 3.94 (1H, s) 77.0 4.04 (1H, s) 77.1 3.94 (1H, s) 77.1
16 177.6 177.6 177.6 177.6
17 3.39 (2H, m) 38.3 3.38 (2H, m) 38.3 3.48 (2H, m) 38.4 3.39 (2H, m) 38.3
18 2.39 (2H, m) 38.2 2.37 (2H, m) 38.2 2.47 (2H, m) 38.2 2.38 (2H, m) 38.2
19 176.9 176.8 176.8 176.9
20 3.34 (2H, m) 41.5 3.30 (2H, m) 41.6 3.40 (2H, m) 41.7 3.33 (2H, m) 41.6
21 3.05 (2H, m) 31.0 2.99 (2H, m) 30.9 3.08 (2H, m) 30.9 3.02 (2H, m) 30.9
22 196.1 195.9 195.7 195.9
23 6.66 (1H, d, J 16.0) 127.0 6.38 (1H, d, J 15.5) 121.3 6.38 (1H, d, J 16.0) 124.3 6.38 (1H, d, J 16.0) 124.5
24 7.33 (1H, d, J 16.0) 144.5 7.20 (1H, d, J 15.5) 144.5 7.18 (1H, d, J 16.0) 144.7 144.6
25 133.9 128.5 128.9 129.0
26 7.43 (1H, dd, J 1.5, 8.0) 131.3 7.22 (1H, dd, J 1.5, 9.0) 118.7 6.83 (1H, br s) 113.7 6.86 (1H, s) 117.8
27 7.37 (1H, m) 131.9 6.70 (1H, dd, J 1.5, 9.0) 133.5 150.9 150.2
28 7.37 (1H, m) 136.3 161.3 150.2 147.0
29 7.37 (1H, m) 131.9 6.70 (1H, dd, J 1.5, 9.0) 133.5 6.74 (1H, d, 8.5) 118.3 6.72 (1H, d, 8.0) 118.9
30 7.43 (1H, dd, J 1.5, 8.0) 131.3 7.22 (1H, dd, J 1.5, 9.0) 118.7 6.79 (1H, dd, J 1.5, 8.5) 126.5 6.77 (1H, dd, J 1.5, 8.0) 125.9
−OCH3 3.78 (3H, s) 58.5
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cDNA isolation and functional characterization of CHS 
gene family
A CHS gene family harboring three members, OcCHS1, 
OcCHS2 and OcCHS3, was isolated from O. caudatum 
(Table  1). After sequence verification, the three full-
length cDNA sequences were inserted into pET-28a 
(+) to yield recombinant pET-28a (+) derived vectors 
for heterologous expression, respectively (Additional 
file  1: Table S2). SDS–PAGE (Additional file  4: Fig. S3) 
and Western-blot (Additional file  5: Fig. S4) results had 
indicated the presence of the protein bands representing 
OcCHS1, OcCHS2 and OcCHS3, respectively. Trans-
cinnamoyl CoA (10), 4-coumaroyl CoA (11), caffeoyl 
CoA (12) and feruloyl CoA (13) were then added into the 
crude extracts of three recombinant OcCHSs to attest 
enzymatic activities. HPLC-DAD results showed there is 
a new peak in reaction mixture of OcCHS2 when using 
trans-cinnamoyl CoA (10) (Additional file 6: Fig. S5) and 
4-coumaroyl CoA (11) as substrates (Data not shown), 
respectively. There are no peaks, however, in the reaction 
mixtures of OcCHS1 and OcCHS3 when the four sub-
strates 10–13 were added to the reaction system. LC–MS 
analyses of these new peaks displayed their [M−H]− ion 
of m/z 255.1 and [M+H]− ion of m/z 273.31, correspond-
ing to the calculated mass for pinocembrin chalcone (4) 
and naringenin chalcone (19), respectively. 5  mg puri-
fied products each were produced by HPLC and applied 
to NMR. It is hard, however, to get a clear and complete 
NMR results due to the instability of the two products, 
pinocembrin chalcone (4) and naringenin chalcone (19).
Both of the two chalcones were thought to be rapidly 
isomerized into corresponding (2S)-flavanones [(2S)-
pinocembrin (2) and (2S)-naringenin (21)], which are 
stable and can be monitored by HPLC and NMR analysis, 
under the action of CHI. A new approach based on meta-
bolic engineering, therefore, was applied to functionally 
characterize OcCHSs. Specifically, OcCHSs and MsCHI 
(M91079) from Medicago sativa L. genes were inserted 
into pCDFDuet-1 to afford pCDF-OcCHSs-MsCHI 
(Additional file  1: Table S2). Plasmids pET28a4CL1 and 
pCDF-OcCHSs-MsCHI were then co-transformed into 
E. coli to form an artificial pathway of (2S)-pinocembrin 
(2) biosynthesis. Strain 2 was constructed by grafting 
the genes coding for Oc4CL1, OcCHS2 and MsCHI into 
Transetta (DE3) (Additional file 1: Table S2). Strain 1 and 
3 contained the same set of flavonoid genes as strain2 
with the exception of OcCHS2, which was respectively 
replaced by OcCHS1 and OcCHS3 (Additional file  1: 
Table S2). Strains 1–3 were cultured as described pre-
viously [19, 20, 37]. When 0.1  mM trans-cinnamic acid 
(5) was supplemented in the medium, a new peak with 
the same retention time and UV spectrum as authen-
tic standard (2RS)-pinocembrin (1) was reproducibly 
detected in the engineered strain 2 (Fig. 4). The ion peak 
[M-H]−at m/z 255 in the ESI–MS spectra suggested the 
Table 3 Enzyme activities of recombinant Oc4CL1
The Km and Vmax of recombinant Oc4CL1 proteins were determined from a Lineweaver–Burk plot
Substrate Vmax (µM/s) Vmax (pkat/ug) Km (µM) kcat (s
−1) kcat/Km (s
−1 M−1)
Trans‑cinnamic acid 0.175 21.66 108.52 1.29 11,855.05
p‑coumaric acid 0.356 44.06 16.42 2.62 159,386.65
Caffeic acid 0.546 67.57 79.88 4.01 50,249.26
Ferulic acid 0.917 113.49 87.2 6.74 77,308.62
Fig. 4 HPLC analyses of fermentation products from engineered 
strains harboring OcCHSs using trans‑cinnamic acid (5) as the 
substrate. a the blank control of Transetta (DE3); b HPLC analysis of 
fermentation products from strain 1; c HPLC analysis of fermentation 
products from strain 2; d HPLC analysis of fermentation products 
from strain 3; 1 and 2 refer to the substrate trans‑cinnamic acid (5) 
and the product (2S)‑pinocembrin (2), respectively; the inserted panel 
represented the UV absorbance of the product (2S)‑pinocembrin (2)
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new compound has a molecular weight of 256, which 
is consistent with that of authentic (2RS)-pinocembrin 
(1). The 1H NMR spectrum (Table  4) showed the sig-
nals of following protons: meta-coupled aromatic pro-
tons at δ 5.90 (1H, d, J  =  2.4  Hz, H-6) and 5.94 (1H, 
J  =  2.4  Hz, H-8); a A2B2X type aromatic protons at δ 
7.37 (1H, tr, J =  7.8  Hz, H-4′), 7.41 (2H, tr, J =  7.8  Hz, 
H-3′, H-5′), and 7.49 (2H, d, J  =  7.8  Hz, H-2′, H-6′). 
Furthermore, three aliphatic doublets at δ 5.46 (1H, dd, 
J =  3.0, 12.0  Hz, H-2), 3.09 (1H, dd, J =  12.0, 18.3  Hz, 
H-3a), and 2.78 (1H, J  =  3.0, 18.3  Hz, H-3b), suggest-
ing the presence of a pinocembrin moiety. As shown in 
Table  4, the 13C NMR spectrum presented signals of a 
carbonyl at δ 196.82 (C-4), and an oxygenated methyne 
at δ 80.5 (C-2), and a methylene 44.2 (C-3), which were 
in agreement with the flavanone skeleton. On the basis 
of the above observations, the structrure of 2 was iden-
tified as pinocembrin [14]. The absolute configuration 
of pinocembrin was further assigned by optical rotation 
and circular dichroism (CD) spectroscopy. Compared to 
the control (racemic pinocembrin (1) produced by strain 
4), the CD spectrum of microbial pinocembrin exhibited 
a positive cotton effect at 325 nm and a negative cotton 
effect at 283  nm, which is consistent with the previous 
report [38]. Therefore, the absolute configuration of the 
microbial pinocembrin at C-2 was assigned to be 2S-con-
figured (Fig.  5). This conclusion was further supported 
by the negative optical rotation ([α]D23 −22.0°, c 1.67 mg/
mL, DMSO) of the microbial pinocembrin [14]. Thus, the 
structure of our microbial pinocembrin was determined 
to be (2S)-pinocembrin (2) (Figs. 4, 5; Table 4). No peak, 
however, was detected in the engineered strains 1 and 3. 
These results clearly indicated that OcCHS2 was a bona 
fide chalcone synthase.
Moreover, strain 2 can also produce a major product, 
which was characterized as naringenin based on the ESI–
MS, UV, and NMR data, when the substrate p-coumaric 
acid (6) was added into the culture broth (Additional 
file 7: Fig. S6; Additional file 1: Table S3).
cDNA isolation and functional characterization of CHI gene 
family
A full-length OcCHI cDNA with 633  bp was puri-
fied from O. caudatum by nested PCR (Table 1). After 
sequence verification, the resulting PCR fragment was 
then inserted into pET-28a (+) to acquire the recombi-
nant expression vector pET28aOcCHI after sequence 
verification. Next, pET28aOcCHI was introduced to 
E. coli Transetta (DE3) for heterologous expression. 
SDS–PAGE (Additional file  8: Fig. S7) and western-
blot (Additional file  9: Fig. S8) analyses had an indica-
tive result of soluble expression of OcCHI protein. Both 
pinocembrin chalcone (4) and naringenin chalcone 
(19) are the theoretic substrates of OcCHI. Functional 
identification of OcCHI by in  vitro enzymatic reaction 
was not applicable due to the inaccessibility of the two 
substrates. A pathway procedure based on metabolic 
engineering was therefore applied to functionally char-
acterize OcCHI. Specifically, an artificial gene cluster 
carrying Oc4CL1, OcCHS2 and OcCHI, in the form of 
plasmids pET28a-Oc4CL1 and pCDF-OcCHS2-OcCHI, 
was transferred to E. coli to yield strain 5 (Additional 
file  1: Table S2). Active OcCHI was reflected by the 
microbial production of (2S)-pinocembrin (2). As illus-
trated in Fig. 6, a new peak was reproducibly appeared 
in the fermentation products of strain 5 compared to 
the control. The retention time of the new peak was 
identical to that of the authentic standard pinocembrin. 
The compound was then applied to LC–MS analysis in 
the negative-ion mode. The new compound appeared 
at m/z 255[M-H], indicating that it was pinocembrin. 
However, the amount of pinocembrin in the superna-
tant of the cell culture was too small to be preparatively 
collected for further detection. Moreover, the engi-
neered strain 5 also can produce naringenin after the 
addition of substrate p-coumaric acid (6) (Fig. 6)
Construction and optimization of engineered E. coli 
producing (2S)‑pinocembrin
A gene cluster containing Oc4CL, OcCHS and MsCHI 
was introduced into E. coli for the purpose of microbial 
Table 4 1H and  13C NMR data for  the new fermentation 
product produced by strain 2 using trans-cinnamic acid (5) 
as the substrate (600 MHz for 1H NMR and 150 MHz for 13C 
NMR, D2O, J in Hz, δ in ppm)
Position Fermentation product  
of strain 2 using trans‑cin‑
namic acid as the substrate
Reference
δH δC δH δC
2 5.465dd (3.0, 12.0) 80.46 5.46dd (2.4, 12.6) 80.5
3 2.780dd (3.0, 18.3) 44.21 2.78dd (2.4, 16.8) 44.2
3.094dd (12.6, 18.3) 3.0dd (12.6, 16.8)
4 197.34 197.3
5 165.51 165.6
6 5.897dd (2.4, 23.1) 97.16 5.90 s 97.3
7 168.42 168.6




2′ 7.495d (7.8) 127.35 7.50d (7.8) 127.4
3′ 7.415tr (7.8) 129.70 7.42tr (7.8) 129.8
4′ 7.368tr (7.8) 129.63 7.36tr (7.8) 129.7
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production of (2S)-pinocembrin (2). Due to higher col-
laborative efficiency with Oc4CL1 and OcCHS2, MsCHI 
was chosen for further investigation. To test the effect of 
varied gene organizations in (2S)-pinocembrin (2) bio-
synthetic circuit, another engineered strain (strain 6) 
was also constructed beside strain 2. Strain 6 contained 
two plasmids, pET28a-Oc4CL1-OcCHS2 and pCDF-
MsCHI. Upon IPTG induction, (2S)-pinocembrin (2) 
produced by the two engineered E. coli cells was analyzed 
using HPLC. Unexpectedly, only strain 2 can produce 
3.58 ± 0.16 mg/L (2S)-pinocembrin (2) (Table 5). Strains 
6 had no flavonoid production.
To improve the heterologous expression of pathway 
enzymes, Oc4CL1, OcCHS2 and MsCHI genes were 
optimized for E. coli using the JCat algorithm (http://
www.jcat.de/) [39]. These codon-optimized genes were 
therefore applied to construct five more engineered 
strains, namely strains 7–11 (Additional file  1: Table 
S2). These strains were grown in M9 medium with addi-
tion of trans-cinnamic acid (5) and the yield of (2S)-
pinocembrin (2) was compared by HPLC analysis. To 
test the potential limitations in the engineered pathway, 
OcCHS2 was first chosen to be highly expressed. As illus-
trated in Table 5, when condon-optimized OcCHS2 was 
introduced into E. coli, the resulting strain 7 can pro-
duce 4.42  ±  0.07  mg/L (2S)-pinocembrin (2), 1.23-fold 
than that of the strain 2 (Table  5). The enhancement of 
(2S)-pinocembrin (2) yield in strain 7 was supposed to 
be the result of overexpression of OcCHS2, which leads 
to a more conversion of pinocembrin chalcone (4) from 
trans-cinnamoyl CoA (10). To promote the conversion 
of more (2S)-pinocembrin (2) from pinocembrin chal-
cone (4), overproduction of CHI is necessary. A con-
don-optimized MsCHI was, therefore, also introduced 
into the strain 7 to generate the strain 8. As expected, 
the yield of (2S)-pinocembrin (2) increased further, 
reaching to 5.96 ±  0.24 mg/L (Table 5). To direct more 
trans-cinnamoyl CoA (10) into (2S)-pinocembrin (2) 
biosynthesis, Oc4CL1 was also over-expressed in the 
strain 10. Unexpectedly, although Oc4CL1, OcCHS2 
and MsCHI were highly expressed in the strain 10, the 
yield of (2S)-pinocembrin (2) in the strain 10 declined to 
4.77 ± 0.17 mg/L, only 80 % of that in the strain 8. The 
decline in production was deemed to result from two 
kinds of metabolic burden being placed on the cell. One 
is related to the synthesis of plasmid-encoded proteins. 
Previous studies indicated that the overproduction of 
foreign proteins can cause a metabolic load in the host 
cell, which resulted in a negative effect on E. coli cells 
[40, 41]. In the present investigation, overproduction 
of three heterologous proteins Oc4CL1, OcCHS2 and 
MsCHI in strain 10 may impose metabolic burden on the 
cell, which in turn cause a decline of (2S)-pinocembrin 
(2). Moreover, the redundant metabolites in the path-
way may lead to the imposition of a metabolic load. In 
strain 2, the supply of trans-cinnamoyl CoA (10) was so 
Fig. 5 CD spectrum of (2S)‑pinocembrin (2) produced by strain 2
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surplus that can not be completely directed to biosyn-
thesis of (2S)-pinocembrin (2) by OcCHS2 and MsCHI, 
even highly expressed OcCHS2 (strain 7) and MsCHI 
(strain 8). Therefore, the amount of trans-cinnamoyl 
CoA (10) accumulated in strain 10 due to overproduc-
tion of Oc4CL1, which imposed metabolic burden on E. 
coli cells. This negative effect on E. coli strains exerted 
by metabolites accumulation in turn resulted in the 
lowered yield of (2S)-pinocembrin (2). This notion was 
further supported by the construction of strains 9 and 
11. As with that of the strain 10, the amount of trans-
cinnamoyl CoA (10) was kept constant in strains 9 and 
11. However, the consumption of trans-cinnamoyl CoA 
Fig. 6 HPLC analysis of the fermentation products from strain 5 using trans‑cinnamic acid (5, left panel) or p‑coumaric acid (6, right panel) as the 
the substrate, respectively. a&e blank control; b&f HPLC analysis of the fermentation products of strain 5 using trans‑cinnamic acid (5, left panel) 
and p‑coumaric acid (6, right panel) as the substrates; c&g HPLC analysis of the standard pinocembrin and naringenin; d&h HPLC analysis of the 
fermentation products of strain 2 using trans‑cinnamic acid (5, left panel) and p‑coumaric acid (6, right panel) as the substrates; 1 and 2 refer to 
pinocembrin and naringenin, respectively
Table 5 Heterologous production of  (2S)-pinocembrin (2) 
in various engineered strains





Strain 2 3.58 ± 0.16
Strain 7 4.42 ± 0.07
Strain 8 5.96 ± 0.24 33.20 ± 1.56 36.92 ± 4.10 27.44 ± 3.92
Strain 9 4.13 ± 0.50
Strain 10 4.77 ± 0.17
Strain 11 2.77 ± 0.30
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(10) in both the two strains declined because codon-opti-
mized enzymes were replaced by their normal homologs. 
Therefore, compared to the strain 10, more trans-cin-
namoyl CoA (10) was accumulated in strains 9 and 11, 
which imposed metabolic load on cells and caused a 
declined (2S)-pinocembrin (2) production. In the five 
strains containing codon-optimized pathway enzymes, 
the strain 8 produced the highest titre of (2S)-pinocem-
brin (2). Therefore, the strain 8 was chose to be a start 
strain for further improvement of (2S)-pinocembrin (2) 
production.
Malonyl CoA (17) is one of the (2S)-pinocembrin (2) 
precursors (Fig.  2). The concentration of malonyl CoA 
(17) in E. coli cells was calculated to be only 4–90  mM 
(0.01–0.23 nmol/mg dry weight) [42]. The low content of 
intracellular malonyl CoA (17) is becoming a bottleneck 
of (2S)-pinocembrin (2) yields in engineered E. coli. To 
increase the supply of malonyl CoA (17), various concen-
trations of cerulenin (18) (Fig. 2) was supplemented into 
the fermentative media after the induction period. Ceru-
lenin (18) is an antifungal antibiotic produced by Cepha-
losporium caerulens, which blocks fatty acid biosynthesis 
by inhibiting the β-ketoacyl-acyl carrier protein (ACP) 
synthases FabB and FabF, thereby preventing channeling 
of malonyl CoA (17) into the pathway for fatty acid syn-
thesis and in turn increasing the supply of malonyl CoA 
(17) to (2S)-pinocembrin (2) biosynthesis.
As seen in Table  5, addition of cerulenin (18) to the 
strain 8 culture drastically increased its product titers up 
to 6.2-fold, reaching 36.92 ± 4.1 mg/L (2S)-pinocembrin 
(2) at a concentration of 0.2  mM cerulenin (18). This 
result confirmed that the strong metabolic channeling 
of carbon toward fatty acids is the major competitive 
step in recombinant (2S)-pinocembrin (2) biosynthe-
sis. Higher dosing of cerulenin (18), however, did not 
result in more (2S)-pinocembrin (2) production. When 
0.3 mM cerulenin was added into the medium, the titre 
of (2S)-pinocembrin (2) decreased to 27.44 ± 3.92 mg/L. 
This finding suggests accumulation of microbial (2S)-
pinocembrin (2) is not a cerulenin (18) dosage-depend-
ent manner. The present investigation, together with 
previous report [43], indicated that higher supplemen-
tation of cerulenin (18) resulted in cell death. The det-
rimental effect may be the main reason of low titre of 
microbial (2S)-pinocembrin (2).
Discussion
Pinocembrin (1) is a chiral compound with a chiral center 
at C-2 (Fig. 1). Chiral pinocembrin (1) is a racemic mix-
ture of 2 minor image enantiomers, (2S)-pinocembrin 
(2) and (2R)-pinocembrin (3, Fig. 1). The two enantiom-
ers have shared identical molecular formulas, atom-to-
atom linkages, and bonding distances. These identical 
architectures of these two enantiomers resulted in an 
often-overlooked chirality analysis of microbial pinocem-
brin [18–20, 28, 37, 44]. It has long been known that 
differences in the pharmacokinetic profiles and activity 
of individual stereoisomers exist, and that these differ-
ences can cause significant, sometimes harmful, effects 
in humans [13, 45]. Thalidomide tragedy is an example 
[46, 47]. Although it is not sure whether the two enan-
tiomers of pinocembrin have unwanted side effects, it is 
necessary to analyze the chirality of pinocembrin prior 
to pharmacological testing. The full characterization of 
absolute configuration of microbial (2S)-pinocembrin (2) 
by combination of MS, NMR, CD and optical detection 
is thereby uniquely valuable in the present study (Fig. 5; 
Table 4), which is the first step toward yield improvement 
and further pharmacological testing.
There are at least three enzymes, such as 4CL, CHS 
and CHI, responsible for (2S)-pinocembrin (2) biosyn-
thesis from trans-cinnamic acid (5) (Fig. 2). These three 
enzymes are encoded by a multi-gene family, respec-
tively. It will take much more time to isolate and further 
functionally characterize all of these genes by conven-
tional molecular biology technologies. It is particularly 
important to develop a high-throughput method, allow-
ing for drastically quicker and cheaper genes discovery, 
and leading towards a far more comprehensive view of 
biosynthetic pathway of (2S)-pinocembrin (2) biosynthe-
sis. The advent of next-generation sequencing approach 
such as transcriptomic analysis provides a platform, 
which has been proved to be critical in speeding up of the 
identification of a large number of related genes of sec-
ondary products. In the present investigation, a tremen-
dous amount of sequences was yielded by transcriptomic 
sequencing of O. caudatum. A few candidate genes, 
including Oc4CLs, OcCHSs and OcCHIs, that encode 
putative enzymes of (2S)-pinocembrin (2) biosynthetic 
pathway, were retrived based on the transcriptome analy-
sis (Additional file  1: Table S1). Moreover, in order to 
quickly construct expression vectors used for heterolo-
gous expression of interest genes, an In-Fusion® method 
based on In-Fusion® enzyme was applied for plasmid 
construction, which can greatly improve the ligation effi-
ciency of plasmid fragments. These candidate genes were 
then be functionally identified by combination of in vitro 
enzymatic reaction and multi-enzyme system based on 
metabolic engineering in our laboratory. By combination 
of these biotechnologies, functional characterizations 
of pathway enzymes of (2S)-pinocembrin (2) biosynthe-
sis were performed in a rapid fashion, which provides a 
successful example for gene parts identification used for 
pathway reconstruction.
In the present investigation, seven full-length 4CL-like 
cDNA were obtained from O. caudatum by nested PCR. 
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The seven genes were thus cloned and the corresponding 
recombinant proteins (each with an N-terminal His6-tag) 
were expressed in E. coli (Additional file 2: Fig. S1, Addi-
tional file 3: Fig. S2). In each case, the precise physiologi-
cal/enzymatic functions of the various 4CL-like members 
in the O. caudatum gene family were carried out using 
trans-cinnamic (5), p-coumaric (6), caffeic (7), ferulic 
(8), sinapic (9) and benzoic acids (15) as potential sub-
strates. The products authenticity in the assay mixtures 
were verified unambiguously by HPLC analysis rather 
than by spectrophotometric assays. The data indicated 
that there was only one bona fide 4CL gene, Oc4CL1. 
The result is out of accord with the previous notion that 
4CL is encoded by a small multi-gene family [48–51]. The 
reason why the recombinant Oc4CL2–7 proteins are not 
active is likely because they can not be actively expressed 
in E. coli. On the other hand, there may be several 4CL 
genes in O. caudatum genome, and we did not isolate 
all of them and identify enzymatic activity. These 4CL-
like proteins were therefore carefully checked for their 
amino acid sequences (Additional file  10: Fig. S9). Pro-
tein sequence alignments of these 4CL-likes revealed the 
existence of a conserved box I motif (SSGTTGLPKGV), 
a signature for the superfamily of adenylate-forming 
enzymes including 4CLs, firefly luciferases, nonriboso-
mal polypeptide synthetases and acyl-CoA synthetases 
[52, 53]. The absolute conservation of another con-
served box II motif (GEICIRG), however, seemed to be 
restricted to Oc4CL1 and Oc4CL6. The discrepancy of 
box II in Oc4CL2, 3, 4, 5 and 7 is indicative of their mem-
bers of the superfamily of adenylate-forming enzymes 
without 4CL function. Oc4CL6 shared two highly con-
served peptide motifs, box I and box II, with Oc4CL1. 
Oc4CL6, however, differs in four amino acids (Y238F, 
P278A, M305L and L341I) within a signature motif gen-
erally determining 4CL substrate specificity [52], indica-
tive of its devoid of 4CL function (Additional file 10: Fig. 
S9).
CHS is a well-studied ubiquitous plant-specific type III 
polyketide synthase (PKS) [54–56]. A number of active 
site residues, including Cys164, Phe215, Phe265, His303 
and Asn336, are conserved in CHSs but vary in other 
type III PKSs [54–56]. These conserved amino acids 
played important roles in CHS reaction mechanism. For 
example, Phe265 separates the coumaroyl binding site 
from the cyclization pocket and may function as a mobile 
steric gate during successive rounds of polyketide elonga-
tion [56]. Single site substitution of these conserved sites 
is deemed to result in decreased, even no activity. In the 
present investigation, Phe265 of OcCHS2 was replaced 
by the Ile residue in OcCHS1 and OcCHS3, respectively. 
The substitution of Phe265, therefore, was postulated to 
be a good explanation of no CHS activity of OcCHS1 and 
OcCHS3 (Additional file 11: Fig. S10).
By combination of in  vitro reaction and co-expres-
sion assay, we identified the enzymes related to (2S)-
pinocembrin (2) biosynthesis from one single species 
for the first time. Importantly, as a first step towards 
microbial scale-up production of (2S)-pinocembrin 
(2), combined expressions of these biosynthetic genes 
in E. coli were performed. As illustrated in Table 5, the 
co-expression of genes originating from single plant 
species resulted in low-level de novo production of (2S)-
pinocembrin (2). Also, it is clear that the combined use 
of pathway-encoding genes from the single plant origin 
does not guarantee the best production of flavonoids [57, 
58]. To optimize the (2S)-pinocembrin (2) production, 
several parameters have to be considered. First of all, to 
test the effect of gene organizations on microbial (2S)-
pinocembrin (2) production, two types of gene organiza-
tions were generated in two engineered strains. Results 
indicated only strain 2 can produce (2S)-pinocembrin (2) 
(Table 5). No activity of strain 6 is likely to result from 
inappropriate construction of plasmid pET28a-Oc4CL1-
OcCHS2. In this plasmid, Oc4CL1 and OcCHS2 were 
regulated by their respective expression cassettes. The 
distance between the two expression cassettes is 14 bp. 
The short distance was assumed to be the main reason 
of abnormal transcription or translation of Oc4CL1, or 
OcCHS2, or both, which was assumed to result in no 
activity of strain 6. Moreover, the expression levels could 
be estimated from the gene copy numbers of pathway 
enzymes. The copy numbers of pCDFDuet-1 (CDF ori-
gin) and pET-28a (+) (pBR322 origin) are 20 and 40, 
respectively. The imbalances within (2S)-pinocembrin 
(2) pathway may lead to under-production of pathway 
enzymes. In addition, we can not rule out the possibil-
ity of homologous recombination. Oc4CL1, OcCHS2 
and MsCHI were under the control of T7 promoter 
and RBS (ribosome-binding sequence) in the plasmids 
pET28a-Oc4CL1-OcCHS2 and pCDF-MsCHI. When 
the two plasmids were co-transformed into E. coli, the 
resulting strain 6 contained the three repeats of the T7 
promoter and RBS. A deletion of the repeats is possible 
to take place due to possibly homologous recombina-
tion. The productivity is still low although strain 2 was 
detected to produce (2S)-pinocembrin (2). We hypoth-
esized that the low titer of (2S)-pinocembrin (2) pro-
duction from recombinant E. coli is partially due to the 
low activity of pathway enzymes. Oc4CL1, OcCHS2 and 
MsCHI, therefore, were designed to optimize the codon 
usage for E. coli. The enhancements of (2S)-pinocem-
brin (2) titre was observed in all the strains containing 
E. coli-preferred genes with the exception of strain 11. 
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Unexpectedly, when co-expression of synthetic condon-
optimized Oc4CL1, OcCHS2 and MsCHI was performed 
in strain 11, decreased yield in (2S)-pinocembrin (2) 
was observed (Table  5). Typically, codon-optimization 
of Oc4CL1, OcCHS2 and MsCHI may lead to their over-
expression in the strain 11. Overproduction of the three 
heterologous proteins, however, usually imposes the 
metabolic burden on the strain and in turn results in the 
negative effect on cell physiology. Hence, it is supposed 
that lowered yield of (2S)-pinocembrin (2) in strain 11 
should be caused by overproduction of heterologous 
Oc4CL1, OcCHS2 and MsCHI. Overall, an engineered 
strain, strain 8 with higher titre of 5.96 ± 0.24 mg/L (2S)-
pinocembrin (2) was selected for further improvement. 
At this stage, insufficient levels of the precursor malonyl 
CoA (17) could be limiting for the overall product titers. 
In order to find out whether the availability of malonyl 
CoA (17) was limiting, cultivations were performed in 
which cerulenin (18, up to 0.3  mM) was supplemented 
during the production phases. The exclusive supplemen-
tation of 0.2  mM cerulenin (18) drastically increased 
product titers up to 6.2-fold, reaching 36.92 ± 4.1 mg/L, 
which was comparable to that of the previous reports 
(Table 5) [18, 19].
Although the yields of (2S)-pinocembrin (2) in E. coli 
were increased, there is still room for improvement. 
Common methods used to improve production from 
engineered biosynthetic pathways include, but is not lim-
ited to, enhancing production of pathway enzymes [19, 
20, 37], yield enhancement of the intracellular pool of 
precursors [19, 59] and balancing multi-gene expression 
to optimize flux [18, 57, 60]. It is well recognized that 
optimal protein yield may be achieved either by muta-
genic experiments to create the desired attributes of an 
enzyme or through selection of variant enzymes depos-
ited in public databases with differing kinetic proper-
ties. Typically, codon optimization had been proved to 
be a mutagenesis technique improving the efficiency of 
heterologous protein production in the present and pre-
vious studies [18, 57, 60]. Also, screening various target 
enzymes with desired attributes from the public data-
bases can optimize engineered pathways. There are many 
well-characterized homologs of 4CL [48, 61, 62], CHS 
[63, 64] and CHI [65] in publicly available sequence data-
bases. These variants have differing kinetic properties. 
They may be chosen to investigate their in  vivo perfor-
mance for (2S)-pinocembrin (2) production in the con-
text of the entire (2S)-pinocembrin (2) pathway. The best 
performing variants will be used as the ideal candidates 
for (2S)-pinocembrin (2) production.
Addition of cerulenin (18) can improve the produc-
tivity of (2S)-pinocembrin (2), however, the high cost 
of cerulenin (18) prohibits its use in industrial-scale 
fermentations. Other additional strategies, like recon-
struction of malonate assimilation pathway containing 
two components of matB (encoding malonyl-CoA syn-
thetase) and matC (encoding malonate carrier protein) 
[18, 66], overexpression of multisubunit complex of 
acetyl-CoA carboxylase (ACC) [19, 66, 67] and genetic 
modification in acetate assimilation pathways [66, 67], 
were pursued for improving the intracellular malonyl 
CoA (17) availability in E. coli to circumvent cerulenin 
(18) addition.
In the expression of a multi-gene heterologous path-
way, the activity of a single enzyme may be out of balance 
with that of the other enzymes in the pathway, leading 
to unbalanced carbon flux and the accumulation of an 
intermediate. Varied strategies, like modular metabolic 
strategy [18, 60] and expression correlation analysis [57], 
may be employed to balance the overall pathway.
Besides, selection of appropriate hosts [60], alleviation 
of the metabolic burden [60] and optimization of fer-
mentation conditions [60] should be taken into account 
since they may lead to robust improvement of (2S)-
pinocembrin (2) produced. Availability of such a power-
ful E. coli platform paves the way for scale-up production 
and eventual industrialization of (2S)-pinocembrin (2) 
production.
Conclusions
In the present study, we presented a full characterization 
of absolute configuration of microbial (2S)-pinocembrin 
(2), a chiral molecule with versatile pharmacological 
and biological activities. Also, we isolated and func-
tionally identified gene parts used for pathway recon-
struction of (2S)-pinocembrin (2) biosynthesis in E. coli 
based on transcriptome-wide sequencing in this inves-
tigation. The resulting engineered E. coli can produce 
36.92 ± 4.1 mg/L (2S)-pinocembrin (2), which paves the 
way for yield increase and further pharmacological test-
ing of chiral (2S)-pinocembrin (2).
Methods
Chemicals and enzymes
Trans-cinnamic acid (5), p-coumaric acid (6), caffeic acid 
(7), ferulic acid (8), sinapic acid (9) and benzoic acid (15) 
were obtained from Sigma-Aldrich Co.LLC (St. Louis, 
MO, United States). Racemic pinocembrin (1) was kindly 
presented by Prof. Zhang TT of IMM (Institute of Mate-
ria Medica), China. Cerulenin (18), used for malonyl 
CoA (17) availability experiments, was purchased from 
J&K Scientific Ltd (Beijing, China). In-Fusion® HD Clon-
ing Kit and restriction enzymes were purchased from 
Takara Shuzo Co. Ltd (Kyoto, Japan). KOD Plus Taq DNA 
polymerase was purchased from Toyobo Co. Ltd (Osaka, 
Japan). All other fine chemicals are analytical grade.
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Strains and plasmids
pEASY™-T1 Simple vector was from TransGen Co. 
Ltd (Beijing, China).The E. coli strain Trans1-T1 and 
Transetta(DE3) (TransGen Co. Ltd) were used as a bac-
terial host for recombinant plasmid amplification and 
enzyme expression, respectively. The strain was grown 
in Luria–Bertani medium (10 g/L Bacto-Tryptone, 5 g/L 
Bacto-yeast extract, 10  g/L NaCl) supplemented with 
ampicillin (100 μg/mL) when required for selection.
The expression vector pET-28a (+) and pCDFDuet-1 
were from Novagen (Madison, USA) and used for heter-
ologous expression. The plasmids and strains used in this 
study are provided in Additional file 1: Table S2.
Plant materials
O. caudatum plants were grown under sterile conditions 
on 67-V medium [68] at a temperature of 22 °C and 16 h 
light/8 h dark cycle. The bulbs of O. caudatum were col-
lected and used fresh or were frozen in liquid N2 and 
stored at −80 °C for RNA isolation.
Transcriptome sequencing and analysis
The detailed procedure is the same as the previous 
reports by our laboratory [69–71]. Specifically, a (cDNA) 
sequencing library was prepared from the total RNA of 
O. caudatum using a mRNA-seq Sample Preparation Kit 
(Illumina) following the manufacturer’s protocol. After 
that, the resultant cDNA library could be sequenced 
using Illumina HiSeq™ 2000. Short nucleotide reads 
obtained via Illumina sequencing were assembled by the 
Trinity software to produce error-free, unique contigu-
ous sequences (contigs). Then, these contigs were con-
nected to acquire non-redundant unigenes, which could 
not be extended on either end.
After transcriptome sequencing of O. caudatum, the 
resulting unigenes were aligned by BLAST X to pro-
tein databases like nr, Swiss-Prot, KEGG and COG 
(e  <  0.00001), and aligned by BLAST N to nucleotide 
databases nt (e  <  0.00001), retrieving proteins with the 
highest sequence similarity with the given unigenes along 
with their protein functional annotations. The candidate 
unigenes which were assigned to (2S)-pinocembrin (2) 
biosynthesis pathway based on KEGG pathway analy-
sis, that is 4CL-like (Oc4CLs), CHS-like (OcCHSs) and 
CHI-like homologs (OcCHIs), were retrieved for further 
studies.
cDNA isolation and functional characterization of 4CL gene 
family
Since the assembled sequences were products of de novo 
assemblies, they were considered prone to error. To con-
firm that the sequences represented true gene products, 
experimental verifications were performed by designing 
gene-specific primers for these full-length sequences 
encoding (2S)-pinocembrin (2) pathway enzymes and 
verifying the identity of amplified products by sequenc-
ing of the PCR amplimers. All the oligonucleotides used 
for DNA manipulation are described in the Additional 
file 1: Table S4.
Amplification of full-length cDNA synthesized from 
mRNA extracted from the sterile bulb tissues of O. cau-
datum was performed by a nested PCR method. The 
amplified products were inserted in pEASY™-T1 Simple 
vector for sequencing.
After sequence verifications, these full-length cDNAs 
were inserted into EcoRI/HindIII linearized pET-28a (+) 
using In-Fusion® technology for heterologous expres-
sion as the procedures previously described [69–71]. In 
all cases, successful gene cloning was verified by diges-
tion checks, and the absence of undesired mutations 
introduced during PCR was verified by direct nucleotide 
sequencing.
Induction of Oc4CL proteins expression was carried 
out at 27  °C for 8  h after addition of IPTG with a final 
concentration of 0.4  mM. His-tag recombinant Oc4CL 
proteins were subsequently purified using immobilized 
metal affinity chromatography system. Activity assay 
and biochemical properties analysis of the recombi-
nant proteins were performed differentially. 4CL activ-
ity was determined by measuring the formation of the 
corresponding CoA thioesters from trans-cinnamic 
acid (5) and its derivatives by in  vitro reaction.  100  µL 
crude protein extracts for Oc4CLs (derived from 1  mL 
of culture) was added to the reaction mixture contain-
ing 2.5 mM MgCl2, 2.5 mM ATP and 20 µM substrates 
(trans-cinnamic acid (5), p-coumaric acid (6), caffeic 
acid (7), ferulic acid (8), sinapic acid (9) and benzoic 
acid (15), respectively) in 200 mM Tris-HCl (pH 7.9) in 
a total volume of 1000  μL. The reaction was started by 
the addition of 0.2 mM CoA. The crude protein extracts 
prepared from E. coli [pET28a] and heat denatured pro-
tein extracts derived from E. coli [pET28a-Oc4CLs] were 
used as the controls. After incubated at 30 °C for 15 min, 
40  μL of acetic acid were added to terminate the reac-
tion. The formation of CoA esters was unambiguously 
determined by HPLC-UV, HPLC-MS and 1H and 13C 
NMR. HPLC was performed on a HITACHI instrument 
using a C18 column [YMC-Pack ODS-A (5 µm, 12 nm) 
250 ×  4.6  mm I.D]. Chromatographic condition was as 
follow. Mobile phase (A): 50 mM NH4Ac water (pH 4.6); 
(B): 100  % acetonitrile; gradient elute for 0–7  min: B 
2–50 %, 7–15 min: B 50–50 %, 15~18 min: B 50–100 %; 
flow rate: 1  mL/min; column temperature: 25  °C; sam-
ple size: 25 μL. The detection was made on a UV detec-
tor at 320 nm for enzymatic products of p-coumaric acid 
(6), caffeic acid (7), ferulic acid (8) and sinapic acid (9), 
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270  nm for reaction product of trans-cinnamic acid (5) 
and 259 nm for benzoic acid (15).
LC–MS analysis was performed using an Agilent 1200 
RRLC series HPLC system (Agilent Technologies, Wald-
bronn, Germany) coupled to the QTRAP MS spectrom-
eter (QTRAP 2000, Applied Biosystems/MDS SCIEX) 
tandem mass spectrometer equipped with a Turbo Ion 
spray ion source (Concord, ON, Canada) which was con-
trolled by Analyst 1.5. UV spectra were recorded from 
190 to 400  nm. The mass spectrometer was operated 
in negative ion mode and spectra were collected in the 
enhanced full mass scan mode from m/z 100 to 1000.
NMR spectroscopic data were obtained at 500  MHz 
for 1H NMR and 125  MHz for 13C NMR using the sol-
vent CDCl3 on Bruker-500 spectrometers, respectively. 
Chemical shifts (δ) are given in ppm, coupling constants 
(J) are given in hertz (Hz).
To examine the biochemical properties and kinetic 
parameters of Oc4CL1, purified recombinant protein 
was used. The pH optimum was determined in a buffer 
of 200 mM Tris-HCl containing 20 μM varied substrates, 
2.5 mM ATP, 25 mM MgCl2, and 0.02 mM CoA, in the 
pH range from 5.90 to 9.48 using 1.616 μg pure enzyme 
in a final volume of 200  μL. Samples were incubated at 
30 °C for 2 min.
To determine the optimum temperature, assays were 
performed in the buffer of 200 mM Tris-HCl containing 
20  μM diverse substrates, 2.5  mM ATP, 25  mM MgCl2, 
and 0.02 mM CoA at pH 7.9 for 2 min with various tem-
peratures from 15~50 °C.
Kinetic analysis of Oc4CL1 was conducted by the 
standard assay with a range of concentrations of differ-
ent substrates. The apparent Km (Michaelis–Menten con-
stant) and the maximum rate of OC4CL1 (Vmax) were 
determined graphically by the Lineweaver–Burk plot.
cDNA isolation and functional characterization of CHS 
gene family
The full-length cDNAs of candidate CHS genes were 
isolated from O. caudatum by nested PCR using the 
gene-specific primers (Additional file  1: Table S4). The 
resulting PCR products were cloned into pEASY™-T1 
Simple vector to generate pEASYOcCHSs and verified by 
sequencing (Additional file  1: Table S2). After confirm-
ing the sequences fidelity, the three OcCHS genes were 
functionally identified either by in  vitro reaction or by 
multienzyme-cooperative systems. In vitro enzymatic 
reaction is a simple and direct way to identify gene func-
tion. Specifically, three OcCHS genes were subcloned in 
frame with the polyhistidine tag into the BamHI/HindIII 
sites of pET-28a (+), giving three constructs, pET28aOc-
CHS1~3. Heterologous expression, SDS–PAGE analysis 
and western-blot verification of the recombinant OcCHS 
proteins were performed using the same procedures as 
that of Oc4CLs. After induction by the addition of IPTG, 
1 ml cells were harvested by centrifugation at 10,000g for 
2 min at 4 °C. The resulting cell pellets were resuspended 
in 1 ml of 200 mM Tris-HCl (pH 7.9) and disrupted by 
sonication. Cell debris was removed by centrifugation at 
12,000g for 5 min at 4  °C, and the resulting supernatant 
was used as crude protein extracts for in vitro activities 
of the recombinant OcCHS proteins. OcCHS activi-
ties were determined by measuring the formation of the 
corresponding chalcones from CoA thioesters. Enzyme 
activities were carried out at 30 °C for 30 min in 1 ml of 
200 mM Tris-HCl (pH 7.9) containing 0.2 mM CoA thi-
oesters and 20 μM malonyl-CoA. The reactions were ter-
minated by adding 40  μl acetic acid and then extracted 
three times with 1.5 ml ethyl acetate. After vortexing and 
centrifugation (12,000g, 10  min), the top organic layer 
was separated and evaporate to dryness, and then the 
remaining residue was resolubilized with 250  μl metha-
nol. The resulting methanol samples were then analyzed 
by HPLC and LC–MS using the same program as that for 
Oc4CLs. UV detection was performed at 341  nm. The 
function of OcCHSs was also characterized using multi-
enzyme-cooperative systems owing to the unstability of 
pinocembrin chalcone (4), a product to CHS reaction. 
Specifically, The candidate OcCHSs were co-expressed 
with a Oc4CL1 and chalcone isomerase from Medicago 
sativa (MSCHI, GenBank accession number M91079) 
[27, 31, 72, 73] in E. coli Transetta (DE3) to form a (2S)-
pinocembrin (2) biosynthetic pathway. The instable 
pincembrin chalcone (4) produced by CHS was then bio-
transformed into (2S)-pinocembrin (2), which was vali-
dated by HPLC analysis, under the action of MsCHI.
First of all, a synthetic MsCHI was inserted into 
BamHI/HindIII sites of pCDFDuet-1, resulting in pCDF-
MsCHI. OcCHSs genes were PCR amplified from respec-
tive pET28a-derived plasmids and were then ligated 
into pCDF-MsCHI between NdeI and XhoI sites, yield-
ing pCDF-OcCHSs-MsCHI (OcCHSs refer to OcCHS1, 
OcCHS2 and OcCHS3). Both OcCHS and MsCHI were 
separately placed under the control of the T7 promoter of 
pCDFDuet-1.
Corresponding plasmids were transformed into E. coli 
Transetta (DE3). The resulting three E. coli recombinant 
strains, strains 1–3, harboring either of the plasmids 
pCDF-OcCHS1-MsCHI, pCDF-OcCHS2-MsCHI or 
pCDF-OcCHS3-MsCHI together with plasmid pET28a-
Oc4CL1 were used for shake flask experiments in 50 mL 
M9 minimal medium with addition of 0.1 mM trans-cin-
namic acid (5) as previous described (Additional file  1: 
Table S2) [31]. Incubation continued at 30  °C for 36  h 
prior to analysis of fermentation products. To analyze fla-
vonoid production, E. coli cells were separated through 
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centrifugation (8000 rpm, 10 min, 4 °C). After extraction 
of the supernatant with an equal volume of ethyl acetate 
three times, the resulting top organic layer were concen-
trated by evaporation and dissolved in 200 μL of metha-
nol. 20 μL of this was injected into HPLC for UV spectra 
and mass spectrometer analysis using the same proce-
dure mentioned above with the exception of monitoring 
absorbance at 290  nm. Absolute configuration of the 
fermentation product was further fully characterized by 
combination of 1H and 13C NMR (600  MHz), CD spec-
troscopy and optical detection. Also, the strain 4, har-
boring plasmids pET28a-Oc4CL1 and pCDF-OcCHS2, 
was constructed for microbial production of racemic 
pinocembrin (1) used as the control for absolute configu-
ration characterization of (2S)-pinocembrin (2).
cDNA isolation and functional characterization of CHI gene 
family
OcCHI gene isolation and protein expression were per-
formed using the same procedure as described above. 
The functional characterization of OcCHI was also per-
formed using multienzyme-cooperative systems due to 
the unavailable pinocembrin chalcone (4), a substrate of 
OcCHI. An artificial gene cluster containing Oc4CL1, 
OcCHS2 and OcCHI was grafted to E. coli Transetta 
(DE3) to rebuild a (2S)-pinocembrin (2) pathway. The 
OcCHI activity is reflected by the production of (2S)-
pinocembrin (2). To this end, a plasmid named pCDF-
OcCHS2-OcCHI was constructed by replacement 
of MsCHI with OcCHI in the parental vector pCDF-
OcCHS2-MsCHI (Additional file  1: Table S2). Plasmids 
pCDF-OcCHS2-OcCHI and pET28aOc4CL1 were then 
co-transformed into Transetta (DE3) to achieve strain 5 
(Additional file 1: Table S2). The fermentation procedure, 
as well as the HPLC analysis and structural characteriza-
tion of the fermentation products was same as described 
above.
Construction and optimization of engineered E. coli 
producing (2S)‑pinocembrin
To test the effect of coordinated expression of pathway 
enzymes on (2S)-pinocembrin (2) production, another 
plasmid, pET28a-Oc4CL1-OcCHS2, was constructed 
(Additional file  1: Table S2). The detailed procedure is 
as follows. OcCHS2 expression cassette containing T7 
promoter, RBS and OcCHS2 ORF was PCR amplified 
from pET28a-OcCHS2. The resulting PCR fragment was 
inserted into pET28a-Oc4CL1 between restriction sites 
BglII/SphI generating pET28a-Oc4CL1-OcCHS2. Plas-
mids pET28a-Oc4CL1-OcCHS2 and pCDF-MsCHI were 
then co-introduced into Transetta (DE3) to create strain 
6 (Additional file  1: Table S2). In strain 2, Oc4CL1 was 
placed in different plasmids from OcCHS2 and MsCHI. 
Oc4CL1 and OcCHS2, however, were placed in the pET-
28a (+), which is different from MsCHI, in strain 6.
In an attempt to increase the expression level of (2S)-
pinocembrin (2) pathway enzymes, Oc4CL1, OcCHS2 
and MsCHI were codon-optimized for E. coli expres-
sion (http://www.jcat.de/), respectively. In future refer-
ences, synthetic genes/proteins are denoted by a prefix 
‘‘opt’’. Three more plasmids pET28a-OptOc4CL1, pCDF-
OptOcCHS2-MsCHI and pCDF-OptOcCHS2-Opt-
MsCHI, carrying synthetic codon optimized Oc4CL1 
(OptOc4CL1), OcCHS2 (OptOcCHS2) and MsCHI (Opt-
MsCHI), were in turn generated using the same proce-
dure that was used to generate their parental plasmids 
pET28a-Oc4CL1 and pCDF-OcCHS2-MsCHI (Addi-
tional file  1: Table S2). Varied plasmids combinations 
were introduced into Transetta (DE3) to generate strains 
7–11 (Additional file 1: Table S2).
Moreover, to improve malonyl CoA (17) availabil-
ity, varied concentrations of cerulenin (18) (0.1, 0.2 and 
0.3  mM) were added into medium to culture strain 8 
(Additional file 1: Table S2) [74–76]. The culture of these 
strains, extraction, HPLC analysis, and fully structural 
characterizations of fermentation products were per-
formed as described above. The flavonoid productions 
from the various recombinant strains were presented as 
the averages of three independent experiments.
Additional files
Additional file 1: Table S1. Unigenes assigned to every step of (2S)‑
pinocembrin(2) biosynthetic pathway. Table S2. Plasmids and strains 
used in this study. Table S3. 1H and 13C NMR data for the new fermen‑
tation product produced by strain 2 using p‑coumaric acid (6) as the 
substrate (600 MHz for 1H NMR and 150 MHz for 13C NMR, D2O, J in Hz, δ in 
ppm). Table S4. Oligonucleotides used in this investigation.
Additional file 2: Fig. S1. SDS‑PAGE of crude protein extracts from a 
transformant expressing Oc4CL1 (Panel A, lane 1), Oc4CL2 (Panel B, lane 
1), Oc4CL3 (Panel C, lane 1), Oc4CL4 (Panel D, lane 1), Oc4CL5 (Panel E, 
lane 1), Oc4CL6 (Panel F, lane 1), Oc4CL7 (Panel G, lane 1), an empty vector 
transformant (pET‑28a (+), lane 2). M stands for molecular weight markers. 
The migration positions of standards (in kDa) are shown at left and the red 
arrows indicate the recombinant Oc4CL proteins.
Additional file 3: Fig. S2. Western blot analysis of crude protein extracts 
from a transformant expressing Oc4CL1 (Panel A, lane 1), Oc4CL2 (Panel B, 
lane 2), Oc4CL3 (Panel C, lane 3), Oc4CL4 (Panel D, lane 4), Oc4CL5 (Panel 
E, lane 5), Oc4CL6 (Panel F, lane 6), Oc4CL7 (Panel G, lane 7), an empty 
vector transformant (pET‑28a (+), lane CK).
Additional file 4: Fig. S3. SDS‑PAGE of total protein isolated from E. coli 
expressing OcCHS1 (panel A, lane 1), OcCHS2 (panel B, lane 2), OcCHS3 
(panel C, lane 3) or control empty vector (Lane CK). M stands for molecular 
weight markers. The migration positions of standards (in kDa) are shown 
at left and the red arrows indicate the recombinant OcCHS proteins.
Additional file 5: Fig. S4. Western blot analysis of total protein isolated 
from E. coli expressing OcCHS1 (lane 1), OcCHS2 (lane 2), OcCHS3 (lane 3) 
or control empty vector (Lane CK).
Additional file 6: Fig. S5. HPLC analysis of the reaction products of 
recombinant OcCHS2 protein. A, HPLC analysis of the reaction product 
from E.coli[pET28a]; B, HPLC analysis of the reaction products of recom‑
binant Oc4CL1 protein using trans‑cinnamic acid (5) as the substrate; C, 
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Additional file 8: Fig. S7. SDS‑PAGE analysis of total proteins stained 
with silver nitrate. Lane 1, total protein from E. coli expressing OcCHI; 
lane CK, total protein from bacteria containing the empty vector alone; 
Molecular masses of markers are shown to the left in kDa (lane M). The red 
arrows indicate the recombinant OcCHI protein.
Additional file 9: Fig. S8. Western blot analysis of total protein isolated 
from E. coli expressing OcCHI (lane 1) and control empty vector (Lane CK).
Additional file 10: Fig. S9. Sequences alignment of Oc4CLs. The con‑
served putative AMP‑binding motif (Box I) and the putative catalytic motif 
GEICIRG (Box II) is highlighted by red square. 12 amino acids proposed to 
function as a 4CL substrate specificity code are labelled with solid circles. 
The mutated amino acids between Oc4CL1 and Oc4CL6 are red shaded.
Additional file 11: Fig. S10. Sequences alignment of OcCHS proteins. 
Five conserved amino acids are labelled with solid circles. The mutated 
amino acid in OcCHS1 and OcCHS3 are red shaded.
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